- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
MedPlus's subsidiary received two drug license suspensions for two stores, each for two days, due to rule violations. This could lead to a potential revenue loss of approximately ₹0.0279 Cr.